237 related articles for article (PubMed ID: 22393942)
1. Celecoxib and Bcl-2: emerging possibilities for anticancer drug design.
Winfield LL; Payton-Stewart F
Future Med Chem; 2012 Mar; 4(3):361-83. PubMed ID: 22393942
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in the development of celecoxib analogs as anticancer agents: A review.
Abdelhaleem EF; Kassab AE; El-Nassan HB; Khalil OM
Arch Pharm (Weinheim); 2022 Dec; 355(12):e2200326. PubMed ID: 35996360
[TBL] [Abstract][Full Text] [Related]
3. Developments in synthesis of the anti-inflammatory drug, celecoxib: a review.
Kumar V; Kaur K; Gupta GK; Gupta AK; Kumar S
Recent Pat Inflamm Allergy Drug Discov; 2013 May; 7(2):124-34. PubMed ID: 23565678
[TBL] [Abstract][Full Text] [Related]
4. Anti-apoptotic Bcl-2 fails to form efficient complexes with pro-apoptotic Bak to protect from Celecoxib-induced apoptosis.
Rudner J; Elsaesser SJ; Jendrossek V; Huber SM
Biochem Pharmacol; 2011 Jan; 81(1):32-42. PubMed ID: 20836993
[TBL] [Abstract][Full Text] [Related]
5. Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels.
Shin YK; Park JS; Kim HS; Jun HJ; Kim GE; Suh CO; Yun YS; Pyo H
Cancer Res; 2005 Oct; 65(20):9501-9. PubMed ID: 16230415
[TBL] [Abstract][Full Text] [Related]
6. Enhanced apoptotic effects by downregulating Mcl-1: evidence for the improvement of photodynamic therapy with Celecoxib.
Song J; Chen Q; Xing D
Exp Cell Res; 2013 Jun; 319(10):1491-504. PubMed ID: 23524145
[TBL] [Abstract][Full Text] [Related]
7. Celecoxib-induced apoptosis is enhanced by ABT-737 and by inhibition of autophagy in human colorectal cancer cells.
Huang S; Sinicrope FA
Autophagy; 2010 Feb; 6(2):256-69. PubMed ID: 20104024
[TBL] [Abstract][Full Text] [Related]
8. Structure-based design of potent Bcl-2/Bcl-xL inhibitors with strong in vivo antitumor activity.
Zhou H; Aguilar A; Chen J; Bai L; Liu L; Meagher JL; Yang CY; McEachern D; Cong X; Stuckey JA; Wang S
J Med Chem; 2012 Jul; 55(13):6149-61. PubMed ID: 22747598
[TBL] [Abstract][Full Text] [Related]
9. Celecoxib activates a novel mitochondrial apoptosis signaling pathway.
Jendrossek V; Handrick R; Belka C
FASEB J; 2003 Aug; 17(11):1547-9. PubMed ID: 12824303
[TBL] [Abstract][Full Text] [Related]
10. Imatinib-resistant K562 cells are more sensitive to celecoxib, a selective COX-2 inhibitor: role of COX-2 and MDR-1.
Arunasree KM; Roy KR; Anilkumar K; Aparna A; Reddy GV; Reddanna P
Leuk Res; 2008 Jun; 32(6):855-64. PubMed ID: 18083230
[TBL] [Abstract][Full Text] [Related]
11. Targeting the Bcl-2-regulated apoptosis pathway by BH3 mimetics: a breakthrough in anticancer therapy?
Labi V; Grespi F; Baumgartner F; Villunger A
Cell Death Differ; 2008 Jun; 15(6):977-87. PubMed ID: 18369371
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of anti-apoptotic Bcl-2 family members Mcl-1, Bcl-2, and Bcl-xL on celecoxib-induced apoptosis.
Rudner J; Elsaesser SJ; Müller AC; Belka C; Jendrossek V
Biochem Pharmacol; 2010 Jan; 79(1):10-20. PubMed ID: 19665451
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus type 5 E1A-induced apoptosis in COX-2-overexpressing breast cancer cells.
Sugimoto T; Bartholomeusz C; Tari AM; Ueno NT
Breast Cancer Res; 2007; 9(4):R41. PubMed ID: 17612393
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic effect of 2, 5-dimethyl-celecoxib as a structural analog of celecoxib on human colorectal cancer (HT-29) cell line.
Nikanfar S; Atari-Hajipirloo S; Kheradmand F; Rashedi J; Heydari A
Cell Mol Biol (Noisy-le-grand); 2018 May; 64(7):8-13. PubMed ID: 29974839
[TBL] [Abstract][Full Text] [Related]
15. Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt.
Liu B; Shi ZL; Feng J; Tao HM
Cell Biol Int; 2008 May; 32(5):494-501. PubMed ID: 18078766
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological evaluation of new celecoxib analogs as apoptosis inducers and cyclooxygenase-2 inhibitors.
Abdelhaleem EF; Kassab AE; El-Nassan HB; Khalil OM
Arch Pharm (Weinheim); 2022 Nov; 355(11):e2200190. PubMed ID: 35976138
[TBL] [Abstract][Full Text] [Related]
17. Celecoxib derivatives induce apoptosis via the disruption of mitochondrial membrane potential and activation of caspase 9.
Ding H; Han C; Zhu J; Chen CS; D'Ambrosio SM
Int J Cancer; 2005 Feb; 113(5):803-10. PubMed ID: 15499625
[TBL] [Abstract][Full Text] [Related]
18. Endoplasmic reticulum stress response as a possible mechanism of cyclooxygenase-2-independent anticancer effect of celecoxib.
Cha W; Park SW; Kwon TK; Hah JH; Sung MW
Anticancer Res; 2014 Apr; 34(4):1731-5. PubMed ID: 24692703
[TBL] [Abstract][Full Text] [Related]
19. BH3 mimetics: status of the field and new developments.
Billard C
Mol Cancer Ther; 2013 Sep; 12(9):1691-700. PubMed ID: 23974697
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibitors of Bcl-2 and Bcl-xL: Balancing antitumor activity with on-target toxicity.
Hennessy EJ
Bioorg Med Chem Lett; 2016 May; 26(9):2105-14. PubMed ID: 26988306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
